Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

http://www.wikidata.org/entity/Q31949934

about

beta -Amyloid peptide-induced apoptosis regulated by a novel protein containing a g protein activation module ApoE promotes the proteolytic degradation of Abeta Role of apolipoprotein E in neurodegenerative diseases Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift Apolipoprotein E knockout mice have accentuated malnutrition with mucosal disruption and blunted insulin-like growth factor I responses to refeeding.Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development Apolipoprotein E4 influences growth and cognitive responses to micronutrient supplementation in shantytown children from northeast Brazil Lipoproteins in the central nervous system.Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models.Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease.Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease.Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.Cerebral amyloid angiopathy: a systematic review Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling.Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides.SDS-resistant active and thermostable dimers are obtained from the dissociation of homotetrameric beta-glycosidase from hyperthermophilic Sulfolobus solfataricus in SDS. Stabilizing role of the A-C intermonomeric interface.Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival.Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.Expression and purification of recombinant tung tree diacylglycerol acyltransferase 2.

P2860

Q24291033-1A8B48A4-DC29-4D2F-ABAC-6C8887865A87 Q24651102-5476BE45-1E4B-4D37-AA63-4B5E0C0DC4DF Q26799413-A005ED01-6603-4EC5-B103-3A7BF18CC1BD Q28582464-B761DD16-50B0-4815-8244-43E53D3171FC Q30410797-E05521B4-F84E-4FFA-86BA-577ACB934230 Q30413759-5C4F4A7D-6F00-483E-8F32-38159FCBA171 Q30429007-CFDD3205-35AE-4B9D-A123-A6B0ACDC253B Q33922696-AA4A2545-4CAB-431F-838F-E03DFADB3458 Q33998693-1BDCF71F-55C7-4FBD-A661-2C7599A422FC Q34526548-1F91BD4F-29D9-4FA3-91E7-9102F25124EF Q35084110-AFF825FA-5D8F-41C7-8F74-ACD20369D432 Q35209894-13D5CB8C-FC83-412F-ABAF-FC28E7238A10 Q35442817-67602650-896D-4EBA-AA13-377FBF145D65 Q36135518-EC280DC9-793F-478F-9352-A2DF5A284A07 Q36448521-F50E62AA-89FE-4CBF-B374-F0296169ED75 Q36635968-EE7E0B2D-9999-4559-91BC-89340F29B1C7 Q37118356-4D915B72-7EC2-49EE-AB41-20205FEBE0C6 Q37868950-451FED17-0E50-459D-9661-407DED61F605 Q38175420-B9D7A727-A34A-4BCB-BC7D-68D10B0A7670 Q38190156-4CC8D49A-DB29-4E41-9FEC-4EDCF747D5BF Q40168518-8CC3FCA6-6D50-436F-BD99-A143C6DB5440 Q42203052-F552B52D-C7DF-43D0-BF3F-F3E85D7E11F7 Q44126957-AE467721-1C28-431C-BF97-D94A26F57E69 Q44158602-2FF493C7-195F-475D-B365-59716D5797BE Q47441289-A8E96975-77F0-42D3-B196-FF8BFBA9B14A Q47570646-5BEB67D5-F9C2-448A-862A-4FF7DE6F1E95 Q48744526-1FC4F66B-DA9F-47AF-9783-DF608EE16B36 Q54343693-8CC74529-B315-4B08-A7A5-4729DD76F606

P2860

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

http://www.wikidata.org/entity/Q31949934

description

1998 nî lūn-bûn

@nan

1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

@ast

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

@en

type

label

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

@ast

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

@en

prefLabel

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

@ast

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

@en

P1433

Q31949934-4E7C1A44-C769-4E92-8FB2-231828AA1854

P1476

Q31949934-85A56594-17DA-4E67-A9F8-E678BD14405B

P2093

Q31949934-04B50706-A630-4340-99AE-131F27BAA955

Q31949934-498B1393-A533-43F9-A270-F7BB967B9B88

Q31949934-9CD43EBE-0F0B-4E53-A590-7B9109A998F5

Q31949934-B1E5B1DB-11F3-46BF-946A-3848C5661A6B

Q31949934-B204CE4F-55B1-42C8-9D71-07D52E924E35

Q31949934-C044853F-EDC1-4CFF-A819-A29B8B2B8318

Q31949934-CD8BBEB8-80BC-4F9A-B793-0513AEABD1CB

Q31949934-EFA6368E-518F-4EBD-A634-B1DF77EC07E8

Q31949934-F7F7E2CD-D724-4363-B78A-400939E4D953

P2860

Q31949934-0A291BB1-33E5-43D4-9DD5-1CCF7F2FA300

Q31949934-0CA1392B-2D0E-4BC6-86E3-111AB3108AF3

Q31949934-17D9EB6C-E83A-4C5A-81F9-D3B937814975

Q31949934-1BEA3E0A-61B7-408E-95B9-AEE08E9BA083

Q31949934-2E6012EA-1448-4E85-B99A-AC206D9EA81D

Q31949934-364B1B2D-A4BE-45AE-B55E-829B843FBF07

Q31949934-3AE1DFAC-8BBB-438B-890E-6C3D1248807D

Q31949934-3CCA8EE6-0CAB-48D5-92DF-6898D3020232

Q31949934-489D8916-1794-4138-9AAE-7E257EAEEA67

Q31949934-647B6F4D-D7A4-4C10-B5A9-DD91E1DA45CC

P304

Q31949934-83C87B8D-F9B4-4099-B571-0530D77FEFE3

P31

Q31949934-CA978E96-61DB-4CF8-AE39-FD15A4EEB66E

P356

Q31949934-428D72BA-CE92-4558-8F7A-B05B36226A56

P407

Q31949934-746B496B-FA2F-4BAE-B17C-A9FDAC38A2B2

P433

Q31949934-5C01BEB2-C63C-4796-946C-A2432F557F08

P478

Q31949934-D8DB52C7-B531-493D-9788-F35470B7432E

P50

Q31949934-950B792B-5BE0-4397-8933-34605B7B5367

Q31949934-D7AF0999-B2F6-4C72-85AD-EB15F4DE6276

P577

Q31949934-2EA29689-CB9B-4D3D-B929-C042D7CFF87C

P5875

Q31949934-182DE63D-53C3-44A0-AC1B-0665E1BCC4A3

P698

Q31949934-D9FC2CE4-8A5A-45C7-B8D8-CF8FB530E6D8

P921

Q31949934-A451883B-FFA0-408B-A270-FB87FEABED8C

P932

Q31949934-F7345DDB-67AF-480C-AC20-3D25315CF071

P356

PNAS.95.26.15598

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease

@en

P2093

A Piccini

http://www.w3.org/2001/XMLSchema#string

D Dapino

http://www.w3.org/2001/XMLSchema#string

D Zaccheo

http://www.w3.org/2001/XMLSchema#string

G Piombo

http://www.w3.org/2001/XMLSchema#string

G Schettini

http://www.w3.org/2001/XMLSchema#string

J K Teller

http://www.w3.org/2001/XMLSchema#string

M Tabaton

http://www.w3.org/2001/XMLSchema#string

P Gambetti

http://www.w3.org/2001/XMLSchema#string

S Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Abnormal in vivo metabolism of apolipoprotein E4 in humans.

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets.

P304

15598-15602

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.26.15598

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Giovanna Angelini

P577

1998-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13426830

http://www.w3.org/2001/XMLSchema#string

P698

9861015

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

28089

http://www.w3.org/2001/XMLSchema#string